Other News

takeda oral orexin narcolepsy type 1
Sleep Pharmaceuticals Narcolepsy Product/Vendor Updates

First Global Phase 3 Trials of Narcolepsy Type 1 Oral Orexin Agonist

Takeda has announced positive topline results from a randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-861, an oral orexin receptor 2 (OX2R) agonist, in patients with narcolepsy type 1. Narcolepsy is a chronic, rare neurological disorder of central hypersomnolence with significant unmet need despite multiple approved therapies. It is […]

sleep and fibromyalgia
Sleep Disorders Research/Studies

Sleep and Fibromyalgia

Fibromyalgia is a complex chronic condition associated with pain, myalgias, and arthralgias, as well as a constitution of other debilitating symptoms such as fatigue and cognitive, gastrointestinal, sleep, and mood issues.1 Sleep disturbances are a hallmark feature of the condition and have a significant bidirectional relationship with other symptomatology, especially […]

zzoma cpap alternative
CPAP/Interfaces Industry News Obstructive Sleep Apnea Product/Vendor Updates

Sleep Specialists Partners with iSleep Physicians to Expand Access to Zzoma Positional Therapy

Sleep Specialists, LLC, the manufacturer of Zzoma® positional therapy for obstructive sleep apnea (OSA), and iSleep Physicians, a leading virtual sleep specialist practice, have announced a collaboration to improve access to effective OSA treatment options for patients nationwide, offering a comfortable and potentially mask-free alternative to traditional CPAP therapy. Zzoma […]